查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1411377

抗毒素市场：按类型划分，2024-2030 年全球预测

Antivenoms Market by Species (Scorpion, Snakes, Spiders), Type (Monovalent Antivenom, Polyvalent Antivenom) - Global Forecast 2024-2030
出版日期: | 出版商: 360iResearch | 英文 193 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计2023年抗毒素市场规模为26.9亿美元，预计2024年将达28.7亿美元，2030年将达43.7亿美元，复合年增长率为7.17%。

全球抗毒素市场

主要市场统计
基准年[2023] 26.9亿美元
预测年份 [2024] 28.7亿美元
预测年份 [2030] 43.7亿美元
复合年增长率（%） 7.17%
抗毒素市场-IMG1

FPNV定位矩阵

FPNV定位矩阵对于评估抗蛇毒血清市场至关重要。我们检视与业务策略和产品满意度相关的关键指标，以对供应商进行全面评估。这种深入的分析使用户能够根据自己的要求做出资讯的决策。根据评估，供应商被分为四个成功程度不同的像限：前沿（F）、探路者（P）、利基（N）和重要（V）。

市场占有率分析

市场占有率分析是一种综合工具，可以对抗蛇毒血清市场供应商的现状进行深入而深入的研究。全面比较和分析供应商在整体收益、基本客群和其他关键指标方面的贡献，以便更好地了解公司的绩效及其在争夺市场占有率时面临的挑战。此外，该分析还提供了对该行业竞争特征的宝贵考察，包括在研究基准年观察到的累积、分散主导地位和合併特征等因素。这种详细程度的提高使供应商能够做出更资讯的决策并制定有效的策略，从而在市场上获得竞争优势。

该报告对以下几个方面提供了宝贵的见解：

1-市场渗透率：提供有关主要企业所服务的市场的全面资讯。

2-市场开拓：我们深入研究利润丰厚的新兴市场并分析其在成熟细分市场的渗透率。

3- 市场多元化：提供有关新产品发布、开拓地区、最新发展和投资的详细资讯。

4-竞争力评估与资讯：对主要企业的市场占有率、策略、产品、认证、监管状况、专利状况、製造能力等进行全面评估。

5- 产品开发与创新：提供对未来技术、研发活动和突破性产品开发的见解。

本报告解决了以下关键问题：

1-抗毒素市场的市场规模和预测是多少？

2-抗毒素市场预测期内需要考虑投资的产品、细分市场、应用和领域有哪些？

3-抗毒素市场的技术趋势和法律规范是什么？

4-抗毒素市场主要供应商的市场占有率是多少？

5-进入抗毒素市场的合适型态和策略手段是什么？

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 蛇咬伤事件增加
      • 提高对可用作急救治疗的抗蛇毒血清的认识
      • 农村医疗卫生基础设施不断完善
    • 抑制因素
      • 抗蛇毒血清生产成本高
    • 机会
      • 抗毒素生产技术进步
      • 改善各国抗毒素的经销网络
    • 任务
      • 缺乏抗蛇毒血清生产的监管标准
  • 市场区隔分析
  • 市场趋势分析
  • 高通膨的累积效应
  • 波特五力分析
  • 价值炼和关键路径分析
  • 法律规范

第六章 抗毒素市场：类型

  • 蝎
  • 蛇
  • 蜘蛛

第七章抗毒素市场：依类型

  • 单价抗毒素
  • 多效价抗毒素

第八章美洲抗毒素市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第九章亚太抗毒素市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十章 欧洲、中东和非洲抗毒素市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十一章竞争形势

  • FPNV定位矩阵
  • 市场占有率分析：主要企业
  • 主要企业竞争情境分析

第12章竞争产品组合

  • 主要公司简介
    • Amsaal LLC
    • BB-NCIPD Ltd.
    • Bharat Serums and Vaccines Limited（BSV）
    • Boehringer Ingelheim International GmbH.
    • BTG International Inc.
    • Creative BioMart
    • CSL
    • Haffkine Bio-Pharmaceutical Corporation Ltd.
    • Incepta Pharma
    • Inosan Biopharma
    • Institute of Vaccines and Medical Biologicals
    • Instituto Clodomiro Picado
    • KM Biologics
    • Laboratorios Silanes, SA de CV
    • Lexicare Pharma Pvt. Ltd.
    • Medtoxin Venom Laboratories, LLC
    • Merck & Co., Inc.
    • MicroPharm
    • Padula Serums Pty Ltd.
    • Pfizer Inc.
    • Rare Disease Therapeutics, Inc.
    • Serum Institute of India Pvt. Ltd.
    • Shanghai Serum Bio-technology Co., Ltd.
    • VINS Bioproducts Ltd.
  • 主要产品系列

第十三章附录

  • 讨论指南
  • 关于许可证和定价
Product Code: MRR-C002B1C994B6

[193 Pages Report] The Antivenoms Market size was estimated at USD 2.69 billion in 2023 and expected to reach USD 2.87 billion in 2024, at a CAGR 7.17% to reach USD 4.37 billion by 2030.

Global Antivenoms Market

KEY MARKET STATISTICS
Base Year [2023] USD 2.69 billion
Estimated Year [2024] USD 2.87 billion
Forecast Year [2030] USD 4.37 billion
CAGR (%) 7.17%
Antivenoms Market - IMG1

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Antivenoms Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Antivenoms Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Antivenoms Market, highlighting leading vendors and their innovative profiles. These include Amsaal LLC, BB - NCIPD Ltd., Bharat Serums and Vaccines Limited (BSV), Boehringer Ingelheim International GmbH., BTG International Inc., Creative BioMart, CSL, Haffkine Bio-Pharmaceutical Corporation Ltd., Incepta Pharma, Inosan Biopharma, Institute of Vaccines and Medical Biologicals, Instituto Clodomiro Picado, KM Biologics, Laboratorios Silanes, S.A. de C.V, Lexicare Pharma Pvt. Ltd., Medtoxin Venom Laboratories, LLC, Merck & Co., Inc., MicroPharm, Padula Serums Pty Ltd., Pfizer Inc., Rare Disease Therapeutics, Inc., Serum Institute of India Pvt. Ltd., Shanghai Serum Bio-technology Co., Ltd., and VINS Bioproducts Ltd..

Market Segmentation & Coverage

This research report categorizes the Antivenoms Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Species
    • Scorpion
    • Snakes
    • Spiders
  • Type
    • Monovalent Antivenom
    • Polyvalent Antivenom
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report offers valuable insights on the following aspects:

1. Market Penetration: It presents comprehensive information on the market provided by key players.

2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.

3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.

4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.

5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

1. What is the market size and forecast of the Antivenoms Market?

2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Antivenoms Market?

3. What are the technology trends and regulatory frameworks in the Antivenoms Market?

4. What is the market share of the leading vendors in the Antivenoms Market?

5. Which modes and strategic moves are suitable for entering the Antivenoms Market?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Limitations
  • 1.7. Assumptions
  • 1.8. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

  • 4.1. Introduction
  • 4.2. Antivenoms Market, by Region

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Growing incidences of snake bites
      • 5.1.1.2. Rising awareness of antivenoms available as first-aid
      • 5.1.1.3. Increasing improvements in healthcare infrastructure in rural areas
    • 5.1.2. Restraints
      • 5.1.2.1. High production cost of antivenoms
    • 5.1.3. Opportunities
      • 5.1.3.1. Technical advancements in antivenoms production
      • 5.1.3.2. Improvement in distribution networks of antivenoms in countries
    • 5.1.4. Challenges
      • 5.1.4.1. Lack of regulatory norms for antivenom manufacturing
  • 5.2. Market Segmentation Analysis
  • 5.3. Market Trend Analysis
  • 5.4. Cumulative Impact of High Inflation
  • 5.5. Porter's Five Forces Analysis
    • 5.5.1. Threat of New Entrants
    • 5.5.2. Threat of Substitutes
    • 5.5.3. Bargaining Power of Customers
    • 5.5.4. Bargaining Power of Suppliers
    • 5.5.5. Industry Rivalry
  • 5.6. Value Chain & Critical Path Analysis
  • 5.7. Regulatory Framework

6. Antivenoms Market, by Species

  • 6.1. Introduction
  • 6.2. Scorpion
  • 6.3. Snakes
  • 6.4. Spiders

7. Antivenoms Market, by Type

  • 7.1. Introduction
  • 7.2. Monovalent Antivenom
  • 7.3. Polyvalent Antivenom

8. Americas Antivenoms Market

  • 8.1. Introduction
  • 8.2. Argentina
  • 8.3. Brazil
  • 8.4. Canada
  • 8.5. Mexico
  • 8.6. United States

9. Asia-Pacific Antivenoms Market

  • 9.1. Introduction
  • 9.2. Australia
  • 9.3. China
  • 9.4. India
  • 9.5. Indonesia
  • 9.6. Japan
  • 9.7. Malaysia
  • 9.8. Philippines
  • 9.9. Singapore
  • 9.10. South Korea
  • 9.11. Taiwan
  • 9.12. Thailand
  • 9.13. Vietnam

10. Europe, Middle East & Africa Antivenoms Market

  • 10.1. Introduction
  • 10.2. Denmark
  • 10.3. Egypt
  • 10.4. Finland
  • 10.5. France
  • 10.6. Germany
  • 10.7. Israel
  • 10.8. Italy
  • 10.9. Netherlands
  • 10.10. Nigeria
  • 10.11. Norway
  • 10.12. Poland
  • 10.13. Qatar
  • 10.14. Russia
  • 10.15. Saudi Arabia
  • 10.16. South Africa
  • 10.17. Spain
  • 10.18. Sweden
  • 10.19. Switzerland
  • 10.20. Turkey
  • 10.21. United Arab Emirates
  • 10.22. United Kingdom

11. Competitive Landscape

  • 11.1. FPNV Positioning Matrix
  • 11.2. Market Share Analysis, By Key Player
  • 11.3. Competitive Scenario Analysis, By Key Player

12. Competitive Portfolio

  • 12.1. Key Company Profiles
    • 12.1.1. Amsaal LLC
    • 12.1.2. BB - NCIPD Ltd.
    • 12.1.3. Bharat Serums and Vaccines Limited (BSV)
    • 12.1.4. Boehringer Ingelheim International GmbH.
    • 12.1.5. BTG International Inc.
    • 12.1.6. Creative BioMart
    • 12.1.7. CSL
    • 12.1.8. Haffkine Bio-Pharmaceutical Corporation Ltd.
    • 12.1.9. Incepta Pharma
    • 12.1.10. Inosan Biopharma
    • 12.1.11. Institute of Vaccines and Medical Biologicals
    • 12.1.12. Instituto Clodomiro Picado
    • 12.1.13. KM Biologics
    • 12.1.14. Laboratorios Silanes, S.A. de C.V
    • 12.1.15. Lexicare Pharma Pvt. Ltd.
    • 12.1.16. Medtoxin Venom Laboratories, LLC
    • 12.1.17. Merck & Co., Inc.
    • 12.1.18. MicroPharm
    • 12.1.19. Padula Serums Pty Ltd.
    • 12.1.20. Pfizer Inc.
    • 12.1.21. Rare Disease Therapeutics, Inc.
    • 12.1.22. Serum Institute of India Pvt. Ltd.
    • 12.1.23. Shanghai Serum Bio-technology Co., Ltd.
    • 12.1.24. VINS Bioproducts Ltd.
  • 12.2. Key Product Portfolio

13. Appendix

  • 13.1. Discussion Guide
  • 13.2. License & Pricing

LIST OF FIGURES

  • FIGURE 1. ANTIVENOMS MARKET RESEARCH PROCESS
  • FIGURE 2. ANTIVENOMS MARKET SIZE, 2023 VS 2030
  • FIGURE 3. ANTIVENOMS MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. ANTIVENOMS MARKET SIZE, BY REGION, 2023 VS 2030 (%)
  • FIGURE 5. ANTIVENOMS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. ANTIVENOMS MARKET DYNAMICS
  • FIGURE 7. ANTIVENOMS MARKET SIZE, BY SPECIES, 2023 VS 2030 (%)
  • FIGURE 8. ANTIVENOMS MARKET SIZE, BY SPECIES, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 9. ANTIVENOMS MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
  • FIGURE 10. ANTIVENOMS MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 11. AMERICAS ANTIVENOMS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 12. AMERICAS ANTIVENOMS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 13. UNITED STATES ANTIVENOMS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 14. UNITED STATES ANTIVENOMS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 15. ASIA-PACIFIC ANTIVENOMS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 16. ASIA-PACIFIC ANTIVENOMS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 17. EUROPE, MIDDLE EAST & AFRICA ANTIVENOMS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 18. EUROPE, MIDDLE EAST & AFRICA ANTIVENOMS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 19. ANTIVENOMS MARKET, FPNV POSITIONING MATRIX, 2023
  • FIGURE 20. ANTIVENOMS MARKET SHARE, BY KEY PLAYER, 2023

LIST OF TABLES

  • TABLE 1. ANTIVENOMS MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. ANTIVENOMS MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL ANTIVENOMS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. ANTIVENOMS MARKET SIZE, BY SPECIES, 2018-2030 (USD MILLION)
  • TABLE 6. ANTIVENOMS MARKET SIZE, BY SCORPION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 7. ANTIVENOMS MARKET SIZE, BY SNAKES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 8. ANTIVENOMS MARKET SIZE, BY SPIDERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. ANTIVENOMS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 10. ANTIVENOMS MARKET SIZE, BY MONOVALENT ANTIVENOM, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. ANTIVENOMS MARKET SIZE, BY POLYVALENT ANTIVENOM, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. AMERICAS ANTIVENOMS MARKET SIZE, BY SPECIES, 2018-2030 (USD MILLION)
  • TABLE 13. AMERICAS ANTIVENOMS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 14. AMERICAS ANTIVENOMS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 15. ARGENTINA ANTIVENOMS MARKET SIZE, BY SPECIES, 2018-2030 (USD MILLION)
  • TABLE 16. ARGENTINA ANTIVENOMS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 17. BRAZIL ANTIVENOMS MARKET SIZE, BY SPECIES, 2018-2030 (USD MILLION)
  • TABLE 18. BRAZIL ANTIVENOMS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 19. CANADA ANTIVENOMS MARKET SIZE, BY SPECIES, 2018-2030 (USD MILLION)
  • TABLE 20. CANADA ANTIVENOMS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 21. MEXICO ANTIVENOMS MARKET SIZE, BY SPECIES, 2018-2030 (USD MILLION)
  • TABLE 22. MEXICO ANTIVENOMS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 23. UNITED STATES ANTIVENOMS MARKET SIZE, BY SPECIES, 2018-2030 (USD MILLION)
  • TABLE 24. UNITED STATES ANTIVENOMS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 25. UNITED STATES ANTIVENOMS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 26. ASIA-PACIFIC ANTIVENOMS MARKET SIZE, BY SPECIES, 2018-2030 (USD MILLION)
  • TABLE 27. ASIA-PACIFIC ANTIVENOMS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 28. ASIA-PACIFIC ANTIVENOMS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 29. AUSTRALIA ANTIVENOMS MARKET SIZE, BY SPECIES, 2018-2030 (USD MILLION)
  • TABLE 30. AUSTRALIA ANTIVENOMS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 31. CHINA ANTIVENOMS MARKET SIZE, BY SPECIES, 2018-2030 (USD MILLION)
  • TABLE 32. CHINA ANTIVENOMS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 33. INDIA ANTIVENOMS MARKET SIZE, BY SPECIES, 2018-2030 (USD MILLION)
  • TABLE 34. INDIA ANTIVENOMS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 35. INDONESIA ANTIVENOMS MARKET SIZE, BY SPECIES, 2018-2030 (USD MILLION)
  • TABLE 36. INDONESIA ANTIVENOMS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 37. JAPAN ANTIVENOMS MARKET SIZE, BY SPECIES, 2018-2030 (USD MILLION)
  • TABLE 38. JAPAN ANTIVENOMS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 39. MALAYSIA ANTIVENOMS MARKET SIZE, BY SPECIES, 2018-2030 (USD MILLION)
  • TABLE 40. MALAYSIA ANTIVENOMS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 41. PHILIPPINES ANTIVENOMS MARKET SIZE, BY SPECIES, 2018-2030 (USD MILLION)
  • TABLE 42. PHILIPPINES ANTIVENOMS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 43. SINGAPORE ANTIVENOMS MARKET SIZE, BY SPECIES, 2018-2030 (USD MILLION)
  • TABLE 44. SINGAPORE ANTIVENOMS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 45. SOUTH KOREA ANTIVENOMS MARKET SIZE, BY SPECIES, 2018-2030 (USD MILLION)
  • TABLE 46. SOUTH KOREA ANTIVENOMS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 47. TAIWAN ANTIVENOMS MARKET SIZE, BY SPECIES, 2018-2030 (USD MILLION)
  • TABLE 48. TAIWAN ANTIVENOMS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 49. THAILAND ANTIVENOMS MARKET SIZE, BY SPECIES, 2018-2030 (USD MILLION)
  • TABLE 50. THAILAND ANTIVENOMS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 51. VIETNAM ANTIVENOMS MARKET SIZE, BY SPECIES, 2018-2030 (USD MILLION)
  • TABLE 52. VIETNAM ANTIVENOMS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 53. EUROPE, MIDDLE EAST & AFRICA ANTIVENOMS MARKET SIZE, BY SPECIES, 2018-2030 (USD MILLION)
  • TABLE 54. EUROPE, MIDDLE EAST & AFRICA ANTIVENOMS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 55. EUROPE, MIDDLE EAST & AFRICA ANTIVENOMS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 56. DENMARK ANTIVENOMS MARKET SIZE, BY SPECIES, 2018-2030 (USD MILLION)
  • TABLE 57. DENMARK ANTIVENOMS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 58. EGYPT ANTIVENOMS MARKET SIZE, BY SPECIES, 2018-2030 (USD MILLION)
  • TABLE 59. EGYPT ANTIVENOMS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 60. FINLAND ANTIVENOMS MARKET SIZE, BY SPECIES, 2018-2030 (USD MILLION)
  • TABLE 61. FINLAND ANTIVENOMS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 62. FRANCE ANTIVENOMS MARKET SIZE, BY SPECIES, 2018-2030 (USD MILLION)
  • TABLE 63. FRANCE ANTIVENOMS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 64. GERMANY ANTIVENOMS MARKET SIZE, BY SPECIES, 2018-2030 (USD MILLION)
  • TABLE 65. GERMANY ANTIVENOMS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 66. ISRAEL ANTIVENOMS MARKET SIZE, BY SPECIES, 2018-2030 (USD MILLION)
  • TABLE 67. ISRAEL ANTIVENOMS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 68. ITALY ANTIVENOMS MARKET SIZE, BY SPECIES, 2018-2030 (USD MILLION)
  • TABLE 69. ITALY ANTIVENOMS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 70. NETHERLANDS ANTIVENOMS MARKET SIZE, BY SPECIES, 2018-2030 (USD MILLION)
  • TABLE 71. NETHERLANDS ANTIVENOMS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 72. NIGERIA ANTIVENOMS MARKET SIZE, BY SPECIES, 2018-2030 (USD MILLION)
  • TABLE 73. NIGERIA ANTIVENOMS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 74. NORWAY ANTIVENOMS MARKET SIZE, BY SPECIES, 2018-2030 (USD MILLION)
  • TABLE 75. NORWAY ANTIVENOMS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 76. POLAND ANTIVENOMS MARKET SIZE, BY SPECIES, 2018-2030 (USD MILLION)
  • TABLE 77. POLAND ANTIVENOMS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 78. QATAR ANTIVENOMS MARKET SIZE, BY SPECIES, 2018-2030 (USD MILLION)
  • TABLE 79. QATAR ANTIVENOMS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 80. RUSSIA ANTIVENOMS MARKET SIZE, BY SPECIES, 2018-2030 (USD MILLION)
  • TABLE 81. RUSSIA ANTIVENOMS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 82. SAUDI ARABIA ANTIVENOMS MARKET SIZE, BY SPECIES, 2018-2030 (USD MILLION)
  • TABLE 83. SAUDI ARABIA ANTIVENOMS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 84. SOUTH AFRICA ANTIVENOMS MARKET SIZE, BY SPECIES, 2018-2030 (USD MILLION)
  • TABLE 85. SOUTH AFRICA ANTIVENOMS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 86. SPAIN ANTIVENOMS MARKET SIZE, BY SPECIES, 2018-2030 (USD MILLION)
  • TABLE 87. SPAIN ANTIVENOMS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 88. SWEDEN ANTIVENOMS MARKET SIZE, BY SPECIES, 2018-2030 (USD MILLION)
  • TABLE 89. SWEDEN ANTIVENOMS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 90. SWITZERLAND ANTIVENOMS MARKET SIZE, BY SPECIES, 2018-2030 (USD MILLION)
  • TABLE 91. SWITZERLAND ANTIVENOMS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 92. TURKEY ANTIVENOMS MARKET SIZE, BY SPECIES, 2018-2030 (USD MILLION)
  • TABLE 93. TURKEY ANTIVENOMS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 94. UNITED ARAB EMIRATES ANTIVENOMS MARKET SIZE, BY SPECIES, 2018-2030 (USD MILLION)
  • TABLE 95. UNITED ARAB EMIRATES ANTIVENOMS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 96. UNITED KINGDOM ANTIVENOMS MARKET SIZE, BY SPECIES, 2018-2030 (USD MILLION)
  • TABLE 97. UNITED KINGDOM ANTIVENOMS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 98. ANTIVENOMS MARKET, FPNV POSITIONING MATRIX, 2023
  • TABLE 99. ANTIVENOMS MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 100. ANTIVENOMS MARKET LICENSE & PRICING